Immunovia AB's market cap is currently kr145.08M. The company's EPS TTM is kr-0.14; its P/E ratio is ―; Immunovia AB is scheduled to report earnings on August 28, 2025, and the estimated EPS forecast is kr-0.06. See an overview of income statement, balance sheet, and cash flow financials.
